XBiotech Inc.

NASDAQ: XBIT · Real-Time Price · USD
3.20
0.00 (0.00%)
At close: Aug 22, 2025, 3:59 PM
3.26
1.87%
After-hours: Aug 22, 2025, 04:43 PM EDT

XBiotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-28.16M -39.41M -38.53M -32.66M -35.01M -30.74M -24.56M -23.13M -28.42M -31.32M -32.9M -36.16M -26.77M -20.24M -17.41M -12.79M -12.05M -13.78M
Depreciation & Amortization
1.76M 1.75M 1.75M 1.74M 1.73M 1.73M 1.74M 1.75M 2.06M 2.35M 2.61M 2.87M 2.83M 2.74M 2.65M 2.53M 2.39M 2.3M
Stock-Based Compensation
4.43M 4.7M 1.75M 1.81M 2.4M 2.94M 3.26M 3.61M 3.79M 4.32M 5.06M 5.38M 5.38M 4.97M 4.46M 5.9M 7.93M 10.06M
Other Working Capital
-3.16M 3K -1.17M 592K 5.19M 3.33M 2.23M 1.33M 4.84M 7.12M 7.24M 10.2M 3.48M 77.53M 78.65M 75.13M 74.67M -1.52M
Other Non-Cash Items
28K 3.66M 5.53M 182K 65K -616K -2.52M 1.99M 3.16M 3.71M 9.29M 5.49M 10.61M -59.84M -67.16M -66.54M -72M -2.69M
Deferred Income Tax
n/a n/a n/a -128K 1.76M 560K 501K 164K -2.08M -1.3M -1.24M -239K 111K 533K 533K -90K -91K -91K
Change in Working Capital
-3.15M -1.19M -1.46M 1.07M 5.42M 4.88M 2.72M 3.02M 4.36M 7.73M 7.6M 8.63M 1.9M 75.04M 79.75M 75.16M 83.43M -1.25M
Operating Cash Flow
-25.09M -30.48M -30.96M -27.86M -23.5M -21.12M -18.73M -12.59M -17.13M -14.51M -14.82M -19.29M -16.66M 62.51M 69.44M 70.81M 81.7M -2.67M
Capital Expenditures
-567K -1.14M -1.3M -1.33M -1.03M -611K -362K -379K -556K -430K -585K -929K -1.42M -3.05M -3.52M -5.27M -5.26M -3.98M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a -3.77M -3.77M -3.77M -3.77M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 61.86M 61.86M 61.86M 58.08M -63.31M -63.31M -63.31M -59.53M n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-567K -1.14M -1.3M -1.33M 60.83M 61.25M 61.5M 57.7M -63.86M -63.74M -63.89M -60.46M -1.42M -3.05M -3.52M -5.27M -5.26M -3.98M
Debt Repayment
-10M -10M 10.25M 10M 10M 10M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 420M 420M 420M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -75M -150.01M -150.01M -150.01M -75M n/a n/a
Other Financial Acitivies
33K 81K 81K 48K 53K -9K -9K -9K -14K n/a n/a 33K 33K 4.01M 5.03M 4.85M 7.08M 3.38M
Financial Cash Flow
-9.9M -9.86M 10.45M 10.17M 10.11M 19.27M 9.21M 9.21M 9.21M n/a n/a 33K -72.01M -68.03M -67.01M -67.19M 7.08M 3.38M
Net Cash Flow
-35.59M -45.14M -27.35M -19.07M 45.14M 48.55M 42.72M 41.62M -82.4M -79.34M -79.68M -78.31M -89.47M -8.06M -383K 446K 85.56M -1.66M
Free Cash Flow
-25.66M -31.62M -32.27M -29.19M -24.53M -21.73M -19.09M -12.97M -17.68M -14.94M -15.41M -20.21M -18.08M 59.46M 65.92M 65.55M 76.44M -6.64M